1ld7: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
m Protected "1ld7" [edit=sysop:move=sysop]
No edit summary
Line 8: Line 8:


==About this Structure==
==About this Structure==
[[1ld7]] is a 2 chain structure of [[Farnesyltransferase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1LD7 OCA].  
[[1ld7]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1LD7 OCA].  


==See Also==
==See Also==

Revision as of 23:06, 20 October 2012

File:1ld7.png

Template:STRUCTURE 1ld7

Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 66Co-crystal structure of Human Farnesyltransferase with farnesyldiphosphate and inhibitor compound 66

Template:ABSTRACT PUBMED 12036349

About this StructureAbout this Structure

1ld7 is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

See AlsoSee Also

ReferenceReference

[xtra 1]

  1. Bell IM, Gallicchio SN, Abrams M, Beese LS, Beshore DC, Bhimnathwala H, Bogusky MJ, Buser CA, Culberson JC, Davide J, Ellis-Hutchings M, Fernandes C, Gibbs JB, Graham SL, Hamilton KA, Hartman GD, Heimbrook DC, Homnick CF, Huber HE, Huff JR, Kassahun K, Koblan KS, Kohl NE, Lobell RB, Lynch JJ Jr, Robinson R, Rodrigues AD, Taylor JS, Walsh ES, Williams TM, Zartman CB. 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency. J Med Chem. 2002 Jun 6;45(12):2388-409. PMID:12036349

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA